{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T07:23:52Z","timestamp":1790234632571,"version":"4.1.0"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100007571","name":"Fondazione Cassa di Risparmio di Civitavecchia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007571","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advances in Biological Regulation"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1016\/j.jbior.2018.03.001","type":"journal-article","created":{"date-parts":[[2018,3,19]],"date-time":"2018-03-19T14:06:19Z","timestamp":1521468379000},"page":"2-9","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Dual inhibition of PI3K\/mTOR signaling in chemoresistant AML primary cells"],"prefix":"10.1016","volume":"68","author":[{"given":"Jessika","family":"Bertacchini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Frasson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Chiarini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniele","family":"D'Avella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benedetta","family":"Accordi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Anselmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrizia","family":"Barozzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Forghieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Luppi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5196-7260","authenticated-orcid":false,"given":"Alberto M.","family":"Martelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Basso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saki","family":"Najmaldin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abbas","family":"Khosravi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2857-4562","authenticated-orcid":false,"given":"Fakher","family":"Rahim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5545-9319","authenticated-orcid":false,"given":"Sandra","family":"Marmiroli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"44","key":"10.1016\/j.jbior.2018.03.001_bib1","doi-asserted-by":"crossref","first-page":"76525","DOI":"10.18632\/oncotarget.20408","article-title":"Targeting signaling and apoptotic pathways involved in chemotherapeutic drug-resistance of hematopoietic cells","volume":"8","author":"Abrams","year":"2017","journal-title":"Oncotarget"},{"issue":"11","key":"10.1016\/j.jbior.2018.03.001_bib2","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1038\/leu.2014.123","article-title":"Feedbacks and adaptive capabilities of the PI3K\/AKT\/mTOR axis in acute myeloid leukemia revealed by pathway selective inhibition and phosphoproteome analysis","volume":"28","author":"Bertacchini","year":"2014","journal-title":"Leukemia"},{"issue":"12","key":"10.1016\/j.jbior.2018.03.001_bib3","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1007\/s00018-015-1867-5","article-title":"Targeting PI3K\/AKT\/mTOR network for treatment of leukemia","volume":"72","author":"Bertacchini","year":"2015","journal-title":"Cell. Mol. Life Sci."},{"issue":"3","key":"10.1016\/j.jbior.2018.03.001_bib4","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.ccr.2014.01.032","article-title":"Clonal evolution enhances leukemia-propagating cell frequency in T cell acute lymphoblastic leukemia through Akt\/mTORC1 pathway activation","volume":"25","author":"Blackburn","year":"2014","journal-title":"Canc. Cell"},{"issue":"6","key":"10.1016\/j.jbior.2018.03.001_bib5","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1038\/sj.leu.2401796","article-title":"P-glycoprotein in primary acute myeloid leukemia and treatment outcome of idarubicin cytosine arabinoside-based induction therapy","volume":"14","author":"Broxterman","year":"2000","journal-title":"Leukemia"},{"issue":"20","key":"10.1016\/j.jbior.2018.03.001_bib6","doi-asserted-by":"crossref","first-page":"8097","DOI":"10.1158\/0008-5472.CAN-10-1814","article-title":"Activity of the novel dual phosphatidylinositol 3-kinase\/mammalian target of rapamycin inhibitor NVP-BEZ235 against T-cell acute lymphoblastic leukemia","volume":"70","author":"Chiarini","year":"2010","journal-title":"Canc. Res."},{"key":"10.1016\/j.jbior.2018.03.001_bib8","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.jbior.2014.07.002","article-title":"PTEN expression and function in adult cancer stem cells and prospects for therapeutic targeting","volume":"56","author":"Ciuffreda","year":"2014","journal-title":"Adv. Biol. Regul"},{"key":"10.1016\/j.jbior.2018.03.001_bib9","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/nm0797-730","article-title":"Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell","volume":"3","author":"Dick","year":"1997","journal-title":"Nat. Med."},{"issue":"12","key":"10.1016\/j.jbior.2018.03.001_bib10","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1056\/NEJMra1406184","article-title":"Acute myeloid leukemia","volume":"373","author":"D\u00f6hner","year":"2015","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.jbior.2018.03.001_bib11","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.jbior.2012.09.009","article-title":"Nuclear phospholipase C \u03b21 signaling, epigenetics and treatments in MDS","volume":"53","author":"Follo","year":"2013","journal-title":"Adv. Biol. Regul"},{"key":"10.1016\/j.jbior.2018.03.001_bib12","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jbior.2014.05.005","article-title":"PTEN and leukemia stem cells","volume":"56","author":"Fragoso","year":"2017","journal-title":"Adv Biol Regul"},{"issue":"1","key":"10.1016\/j.jbior.2018.03.001_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40591-015-0040-8","article-title":"Outlook on PI3K\/AKT\/mTOR inhibition in acute leukemia","volume":"3","author":"Fransecky","year":"2015","journal-title":"Mol. Cell. Ther"},{"issue":"8","key":"10.1016\/j.jbior.2018.03.001_bib14","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1158\/0008-5472.CAN-15-2063","article-title":"Frequency and dynamics of leukemia-initiating cells during short-term ex vivo culture informs outcomes in acute myeloid leukemia patients","volume":"76","author":"Griessinger","year":"2016","journal-title":"Canc. Res."},{"key":"10.1016\/j.jbior.2018.03.001_bib15","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.jbior.2017.06.003","article-title":"GSK3 and its interactions with the PI3K\/AKT\/mTOR signalling network","volume":"65","author":"Hermida","year":"2017","journal-title":"Adv Biol Regul"},{"issue":"11","key":"10.1016\/j.jbior.2018.03.001_bib16","doi-asserted-by":"crossref","first-page":"3605","DOI":"10.1182\/blood.V97.11.3605","article-title":"MDR1 gene\u2013related clonal selection and P-glycoprotein function and expression in relapsed or refractory acute myeloid leukemia","volume":"97","author":"van den Heuvel-Eibrink","year":"2001","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.jbior.2018.03.001_bib17","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1182\/blood-2009-06-229443","article-title":"Constitutively active AKT depletes hematopoietic stem cells and induces leukemia in mice","volume":"115","author":"Kharas","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.jbior.2018.03.001_bib18","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.jbior.2017.11.001","article-title":"Dysregulation of mRNA translation and energy metabolism in cancer","volume":"67","author":"Leibovitch","year":"2018","journal-title":"Adv Biol Regul"},{"issue":"3","key":"10.1016\/j.jbior.2018.03.001_bib19","doi-asserted-by":"crossref","first-page":"248","DOI":"10.4149\/neo_2012_032","article-title":"Perifosine downregulates MDR1 gene expression and reverses multidrug-resistant phenotype by inhibitingPI3K\/Akt\/NF-\u03baB signaling pathway in a human breast cancer cell line","volume":"59","author":"Lin","year":"2012","journal-title":"Neoplasma"},{"issue":"3","key":"10.1016\/j.jbior.2018.03.001_bib20","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1002\/ijc.10203","article-title":"Troglitazione affects survival of human osteosarcoma cells","volume":"98","author":"Lucarelli","year":"2002","journal-title":"Int. J. Canc."},{"issue":"7","key":"10.1016\/j.jbior.2018.03.001_bib21","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1182\/blood-2003-07-2490","article-title":"Targeting the multidrug resistance-1 transporter in AML: molecular regulation and therapeutic strategies","volume":"104","author":"Mahadevan","year":"2004","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.jbior.2018.03.001_bib22","first-page":"243","article-title":"Phosphoinositidase C isozymes in SaOS-2 cells: immunocytochemical detection in nuclear and cytoplasmic compartments","volume":"79","author":"Maraldi","year":"1993","journal-title":"A. Biol Cell."},{"issue":"2","key":"10.1016\/j.jbior.2018.03.001_bib23","first-page":"427","article-title":"Reverse-phase protein microarrays (RPPA) as a diagnostic and therapeutic guide in multidrug resistant leukemia","volume":"38","author":"Maraldi","year":"2011","journal-title":"Int. J. Oncol."},{"issue":"12","key":"10.1016\/j.jbior.2018.03.001_bib24","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0052898","article-title":"PI3K inhibition enhances doxorubicin-induced apoptosis in sarcoma cells","volume":"7","author":"Marklein","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jbior.2018.03.001_bib25","doi-asserted-by":"crossref","first-page":"601543","DOI":"10.1155\/2015\/601543","article-title":"Phosphorylation, signaling, and cancer: targets and targeting","volume":"2015","author":"Marmiroli","year":"2015","journal-title":"BioMed Res. Int."},{"issue":"9","key":"10.1016\/j.jbior.2018.03.001_bib26","article-title":"The emerging role of the phosphatidylinositol 3-kinase\/AKT\/mammalian target of rapamycin signaling network in normal myelopoiesis and leukemogenesis","volume":"1803","author":"Martelli","year":"2010","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.jbior.2018.03.001_bib27","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.jbior.2014.04.004","article-title":"Targeting signaling pathways in T-cell acute lymphoblastic leukemia initiating cells","volume":"56","author":"Martelli","year":"2014","journal-title":"Adv. Biol. Regul"},{"key":"10.1016\/j.jbior.2018.03.001_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jbior.2014.07.001","article-title":"Foreword: \u201cTargeting signaling pathways in stem cells\u201d","volume":"56","author":"McCubrey","year":"2014","journal-title":"Adv. Biol. Regul"},{"issue":"5","key":"10.1016\/j.jbior.2018.03.001_bib29","doi-asserted-by":"crossref","DOI":"10.18632\/oncotarget.6315","article-title":"Reversal of the glycolytic phenotype of primary effusion lymphoma cells by combined targeting of cellular metabolism and PI3K\/Akt\/mTOR signaling","volume":"7","author":"Mediani","year":"2015","journal-title":"Oncotarget"},{"issue":"2","key":"10.1016\/j.jbior.2018.03.001_bib30","first-page":"45","article-title":"Molecular and cellular aspects of extramedullary manifestations of acute myeloid leukemia","volume":"2","author":"Mohammadiasl","year":"2016","journal-title":"J. Cancer Metastasis Treat"},{"issue":"5","key":"10.1016\/j.jbior.2018.03.001_bib31","doi-asserted-by":"crossref","first-page":"819","DOI":"10.3324\/haematol.2009.013797","article-title":"Role of the PI3K\/AKT and mTOR signaling pathways in acute myeloid leukemia","volume":"95","author":"Park","year":"2010","journal-title":"Haematologica"},{"key":"10.1016\/j.jbior.2018.03.001_bib32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jbior.2015.07.001","article-title":"Foreword: \u201cThe PI3-kinase\/Akt pathway: from signaling to diseases\u201d","volume":"59","author":"Payrastre","year":"2015","journal-title":"Adv. Biol. Regul"},{"key":"10.1016\/j.jbior.2018.03.001_bib33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jbior.2017.10.008","article-title":"Nuclear inositide signaling and cell cycle","volume":"67","author":"Ratti","year":"2018","journal-title":"Adv Biol Regul"},{"key":"10.1016\/j.jbior.2018.03.001_bib34","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.jbior.2017.05.002","article-title":"Targeting the Akt, GSK-3, Bcl-2 axis in acute myeloid leukemia","volume":"65","author":"Ricciardi","year":"2017","journal-title":"Adv. Biol. Regul"},{"key":"10.1016\/j.jbior.2018.03.001_bib35","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.jbior.2017.05.001","article-title":"GSK-3 as a novel prognostic indicator in leukemia","volume":"65","author":"Ruvolo","year":"2017","journal-title":"Adv Biol Regul"},{"key":"10.1016\/j.jbior.2018.03.001_bib36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jbior.2017.03.002","article-title":"Cross-talk between the CK2 and AKT signaling pathways in cancer","volume":"64","author":"Ruzzene","year":"2017","journal-title":"Adv. Biol. Regul"},{"issue":"3","key":"10.1016\/j.jbior.2018.03.001_bib37","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3390\/jcm5030033","article-title":"Acute myeloid leukemia: a concise review","volume":"5","author":"Saultz","year":"2016","journal-title":"J. Clin. Med."},{"issue":"23","key":"10.1016\/j.jbior.2018.03.001_bib38","doi-asserted-by":"crossref","first-page":"7048","DOI":"10.1158\/0008-5472.CAN-14-1470","article-title":"Targeting the MYC and PI3K pathways eliminates leukemia-initiating cells in T-cell acute lymphoblastic leukemia","volume":"74","author":"Schubbert","year":"2014","journal-title":"Canc. Res."},{"issue":"1","key":"10.1016\/j.jbior.2018.03.001_bib39","first-page":"1","article-title":"TRAIL sensitize MDR cells to MDR-related drugs by down-regulation of P-glycoprotein through inhibition of DNA-PKcs\/AKT\/GSK-3\u03b2 pathway and activation of caspases","volume":"9","author":"Seo","year":"2010","journal-title":"Mol. Canc."},{"issue":"4","key":"10.1016\/j.jbior.2018.03.001_bib40","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1038\/leu.2017.13","article-title":"Phosphoproteomic analysis reveals hyperactivation of mTOR\/STAT3 and LCK\/Calcineurin axes in pediatric early T-cell precursor ALL","volume":"31","author":"Serafin","year":"2017","journal-title":"Leukemia"},{"key":"10.1016\/j.jbior.2018.03.001_bib41","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.bcp.2017.11.022","article-title":"Targeting PI3K, mTOR, ERK, and BCL-2 signaling network shows superior antileukemic activity against AML ex vivo","volume":"148","author":"Su","year":"2018","journal-title":"Biochem. Pharmacol."},{"issue":"3","key":"10.1016\/j.jbior.2018.03.001_bib43","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1038\/sj.leu.2404523","article-title":"Multidrug resistance-associated protein 1 expression is under the control of the phosphoinositide 3 kinase\/AKT signal transduction network in human acute myelogenous leukemia blasts","volume":"21","author":"Tazzari","year":"2007","journal-title":"Leukemia"},{"issue":"9","key":"10.1016\/j.jbior.2018.03.001_bib44","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0107587","article-title":"Leukemic stem cell frequency: a strong biomarker for clinical outcome in acute myeloid leukemia","volume":"9","author":"Terwijn","year":"2014","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.jbior.2018.03.001_bib45","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1182\/blood-2014-10-551911","article-title":"How I treat refractory and early relapsed acute myeloid leukemia","volume":"126","author":"Thol","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.jbior.2018.03.001_bib46","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.jbior.2014.04.001","article-title":"Signaling specificity in the Akt pathway in biology and disease","volume":"55","author":"Toker","year":"2014","journal-title":"Adv. Biol. Regul"},{"issue":"12","key":"10.1016\/j.jbior.2018.03.001_bib47","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.3324\/haematol.2011.047894","article-title":"High levels of CD34+ CD38low\/\u2212 CD123+ blasts are predictive of an adverse outcome in acute myeloid leukemia: a Groupe Ouest-Est des Leucemies Aigues et Maladies du Sang (GOELAMS) study","volume":"96","author":"Vergez","year":"2011","journal-title":"Haematologica"},{"key":"10.1016\/j.jbior.2018.03.001_bib48","doi-asserted-by":"crossref","first-page":"4286","DOI":"10.1158\/0008-5472.CAN-08-4765","article-title":"PI3K pathway activation mediates resistance to MEK inhibitors in KRAS mutant cancers","volume":"69","author":"Wee","year":"2009","journal-title":"Canc. Res."},{"key":"10.1016\/j.jbior.2018.03.001_bib49","doi-asserted-by":"crossref","first-page":"773","DOI":"10.3892\/or.2013.2520","article-title":"Inhibition of the PI3K\/AKT pathway increases the chemosensitivity of gastric cancer to vincristine","volume":"30","author":"Xie","year":"2013","journal-title":"Oncol. Rep."},{"issue":"3","key":"10.1016\/j.jbior.2018.03.001_bib50","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.jbior.2013.08.003","article-title":"The physiological roles of primary phospholipase C","volume":"53","author":"Yang","year":"2013","journal-title":"Adv Biol Regul"}],"container-title":["Advances in Biological Regulation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212492618300769?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212492618300769?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T22:23:21Z","timestamp":1761949401000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2212492618300769"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":48,"alternative-id":["S2212492618300769"],"URL":"https:\/\/doi.org\/10.1016\/j.jbior.2018.03.001","relation":{},"ISSN":["2212-4926"],"issn-type":[{"value":"2212-4926","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dual inhibition of PI3K\/mTOR signaling in chemoresistant AML primary cells","name":"articletitle","label":"Article Title"},{"value":"Advances in Biological Regulation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jbior.2018.03.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}